NeuroSense Therapeutics Ltd. Salary and Wage, Excluding Cost of Good and Service Sold
NeuroSense Therapeutics Ltd. (NRSN) reported Salary and Wage, Excluding Cost of Good and Service Sold of $931.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SalariesWagesAndOfficersCompensation · last filed 2026-03-31
| Period end | Salary and Wage, Excluding Cost of Good and Service Sold 12 month | Salary and Wage, Excluding Cost of Good and Service Sold 12 month as first filed |
|---|---|---|
| 2025-12-31 | $931.00K 20-F · filed 2026-03-31 | |
| 2024-12-31 | $865.00K 20-F · filed 2026-03-31 | |
| 2023-12-31 | $1.01M 20-F · filed 2026-03-31 | |
| 2022-12-31 | $1.01M 20-F · filed 2025-04-07 | $1.21M 20-F · filed 2023-03-22 |
| 2021-12-31 | $447.00K 20-F · filed 2023-03-22 | |
| 2020-12-31 | $227.00K 20-F · filed 2023-03-22 |